The effects of dobutamine, dopexamine and fluid on hepatic histological responses to porcine faecal peritonitis.
We studied the effects of two catecholamines with differing receptor profiles on hepatic blood flow and hepatic structure in a porcine model of faecal peritonitis. We treated animals with dopexamine (group Dp) or dobutamine (group Db) and fluid, or fluid alone as a control, to achieve a 25% increase in Qt from baseline values. After the induction of faecal peritonitis the increased Qt was maintained throughout the 8 h study period by adjustment of the fluid infusion rate. The dose of catecholamines remained constant. Hepatic blood flow was correspondingly maintained at above baseline values throughout the study. Post-mortem liver biopsy specimens were analysed from experimental animals and 5 sham animals who had not been instrumented or infected. In experimental animals there was a reduction in sinusoidal patency between sham and group Dp (76% of total sinusoid vs 51%, p less than 0.05) and group Dp and control (51% vs 33%, p less than 0.05) or groups Dp and Db (51% vs 34%, p less than 0.05) animals. This was accounted for by an increase in sinusoidal leukocytes and endothelial swelling. In addition to the changes noted above there was marked hepatocellular destruction in group Db. We conclude that maintenance of organ blood flow does not guarantee structural integrity in the sepsis syndrome and hepatocellular damage was greater in group Db than group Dp or control.
Webb
A R
AR
Department of Medicine, St. George's Hospital Medical School, London, UK.
Moss
R F
RF
Tighe
D
D
al-Saady
N
N
Bennett
E D
ED
D000322:Adrenergic Agonists / Q000627:therapeutic use*; D000818:Animals; D004280:Dobutamine / Q000627:therapeutic use*; D004298:Dopamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005440:Fluid Therapy; D006439:Hemodynamics; D008099:Liver / Q000473:pathology*; D008102:Liver Circulation; D010538:Peritonitis / Q000188:drug therapy* / Q000473:pathology; D013552:Swine
D000322:Adrenergic Agonists; C046318:dopexamine; D004280:Dobutamine; D004298:Dopamine